Advertisement

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

Published:March 10, 2008DOI:https://doi.org/10.1016/j.jhep.2008.02.011

      Background/Aims

      While the rise in non-alcoholic fatty liver disease (NAFLD) parallels the increase in obesity and diabetes, a significant increase in dietary fructose consumption in industrialized countries has also occurred. The increased consumption of high fructose corn syrup, primarily in the form of soft drinks, is linked with complications of the insulin resistance syndrome. Furthermore, the hepatic metabolism of fructose favors de novo lipogenesis and ATP depletion. We hypothesize that increased fructose consumption contributes to the development of NAFLD.

      Methods

      A dietary history and paired serum and liver tissue were obtained from patients with evidence of biopsy-proven NAFLD (n = 49) without cirrhosis and controls (n = 24) matched for gender, age (±5 years), and body mass index (±3 points).

      Results

      Consumption of fructose in patients with NAFLD was nearly 2- to 3-fold higher than controls [365 kcal vs 170 kcal (p < 0.05)]. In patients with NAFLD (n = 6), hepatic mRNA expression of fructokinase (KHK), an important enzyme for fructose metabolism, and fatty acid synthase, an important enzyme for lipogenesis were increased (p = 0.04 and p = 0.02, respectively). In an AML hepatocyte cell line, fructose resulted in dose-dependent increase in KHK protein and activity.

      Conclusions

      The pathogenic mechanism underlying the development of NAFLD may be associated with excessive dietary fructose consumption.

      Abbreviations:

      NAFLD (non-alcoholic fatty liver disease), KHK (hexokinase), FAS (fatty acid synthase), XDH (xanthine dehydrogenase)

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Clark J.M.
        • Brancati F.L.
        • Diehl A.M.
        Nonalcoholic fatty liver disease.
        Gastroenterology. 2002; 122: 1649-1657
        • Clark J.M.
        • Brancati F.L.
        • Diehl A.M.
        The prevalence and etiology of elevated aminotransferase levels in the United States.
        Am J Gastroenterol. 2003; 98: 960-967
        • Ioannou G.N.
        • Boyko E.S.
        • Less S.P.
        The prevalence and predictors of elevated serum aminotransferase activity in the Unites States in 1999–2002.
        Am J Gastroenterol. 2003; 98: 960-967
        • Browning J.D.
        • Szczepaniak L.S.
        • Dobbins R.
        • Nuremberg P.
        • Horton J.D.
        • Cohen J.C.
        • et al.
        Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
        Hepatology. 2004; 40: 1387-1395
        • Basciano H.
        • Federico L.
        • Adeli K.
        Fructose, insulin resistance, and metabolic dyslipidemia.
        Nutr Metab (Lond). 2005; 21: 5
        • Nielsen S.J.
        • Popkin B.M.
        Changes in beverage intake between 1977 and 2001.
        Am J Prev Med. 2004; 27: 205-209
        • Ludwig D.S.
        • Peterson K.E.
        • Gortmaker S.L.
        Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis.
        Lancet. 2001; 357: 505-508
        • Schulze M.B.
        • Manson J.E.
        • Lugwig D.S.
        • Colditz G.A.
        • Stamplfer M.J.
        • Willett W.C.
        • et al.
        Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women.
        JAMA. 2004; 292: 927-934
        • Gross L.S.
        • Ford E.S.
        • Liu S.
        Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecological assessment.
        Am J Clin Nutr. 2004; 79: 774-779
        • Dhingra R.
        • Sullivan L.
        • Jacques P.F.
        • Wang T.J.
        • Fox C.S.
        • Meigs J.B.
        • et al.
        Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community.
        Circulation. 2007; 116: 480-488
        • Vartanian L.R.
        • Schwartz M.B.
        • Brownell K.D.
        Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis.
        Am J Public Health. 2007; 97: 667-675
        • Welch J.A.
        • Cogswell M.E.
        • Rogers S.
        • Rockett H.
        • Mei Z.
        • Grummer-Strawn L.M.
        Overweight among low-income preschool children associated with the consumption of sweet drinks: Missouri, 1999–2002.
        Pediatrics. 2005; 115: e223-e229
        • Segal M.S.
        • Gollub E.S.
        • Johnson R.J.
        Is the Fructose Index more relevant with regards to cardiovascular disease than the Glycemic Index?.
        Eur J Nutr. 2007; 46: 406-417
        • Johnson R.J.
        • Segal M.
        • Sautin Y.
        • Nakagawa T.
        • Feig D.I.
        • Kang D.H.
        • et al.
        Potential role of sugar (fructose) in the epidemic of hypertension, obesity/metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
        Am J Clin Nutr. 2007; 86: 899-906
        • Havel P.J.
        Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.
        Nutr Rev. 2005; 63: 133-157
        • Le K.A.
        • Tappy L.
        Metabolic effects of fructose.
        Curr Opin Clin Nutr Metab Care. 2006; 9: 469-475
        • Mendeloff A.I.
        • Weichselbaum T.E.
        Role of the human liver in the assimilation of intravenously administered fructose.
        Metabolism. 1953; 2: 450-458
        • Nakagawa T.
        • Hu H.
        • Zharikov S.
        • Tuttle K.R.
        • Short R.A.
        • Glushakova O.
        • et al.
        A causal role for uric acid in fructose-induced metabolic syndrome.
        Am J Physiol Renal Physiol. 2006; 290: F625-F631
        • Mayes P.A.
        Intermediary metabolism of fructose.
        Am J Clin Nutr. 1993; 58: 754S-765S
        • Wolfe B.M.
        • Ahuja S.P.
        • Marliss E.B.
        Effects of intravenously administered fructose and glucose on splanchnic amino acid and carbohydrate metabolism in hypertriglyceridemic men.
        J Clin Invest. 1975; 56: 970-977
        • Ackerman Z.
        • Oron-Herman M.
        • Grozovski M.
        • Rosenthal T.
        • Pappo O.
        • Link G.
        • et al.
        Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.
        Hypertension. 2005; 45: 1012-1018
        • Davail S.
        • Rideau N.
        • Bernadet M.D.
        • André J.M.
        • Guy G.
        • Hoo-Paris R.
        Effects of dietary fructose on liver steatosis in overfed mule ducks.
        Horm Metab Res. 2005; 37: 32-35
        • Porikos K.P.
        • Van Itallie T.B.
        Diet induced changes in serum transaminases and triglyceride levels in healthy men. Role of sucrose and excess calories.
        Am J Med. 1983; 75: 624-630
        • Howard B.V.
        • Wylie-Rosett J.
        Sugar and cardiovascular disease: a statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association.
        Circulation. 2002; 106: 523-527
        • Bode J.C.
        • Zelder O.
        • Rumpelt H.J.
        • Wittkamp U.
        Depletion of adenosine phosphates and metabolic effects of intravenous infusion of fructose or sorbitol in man and the rat.
        Eur J Clin Invest. 1973; 3: 436-441
        • Hultman E.
        • Nilsson H.
        • Sahlin K.
        Adenine nucleotide content of human liver: normal values and fructose induced depletion.
        Scand J Clin Lab Invest. 1975; 55: 245-251
        • Oberhaensli R.D.
        • Galloway G.J.
        • Taylor D.J.
        • Bore P.J.
        • Radda G.K.
        Assessment of human liver metabolism by phosphorus-1 magnetic resonance spectrosocopy.
        Br J Radiol. 1986; 59: 695-699
        • Cortez-Pinto H.
        • Chatham J.
        • Chacko V.P.
        • Arnold C.
        • Rashid A.
        • Diehl A.M.
        Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
        JAMA. 1999; 282: 1659-1664
        • Adachi F.
        • Yu D.T.
        • Phillips M.J.
        An ultrastructural study of fructose-induced hepatic cell injury.
        Virchows Arch Abteilung B Zellpathol. 1972; 10: 200-209
        • Nandhini A.T.
        • Balakrishnan S.D.
        • Anuradha C.V.
        Response of liver antioxidant system to taurine in rats fed high fructose diet.
        Indian J Exp Biol. 2002; 40: 1016-1019
        • Kelley G.L.
        • Allan G.
        • Azhar S.
        High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation.
        Endocrinology. 2004; 145: 548-555
        • Burant C.F.
        • Saxena M.
        Rapid reversible substrate regulation of fructose transporter expression in rat small intestine and kidney.
        Am J Physiol. 1994; 267: G71-G79
        • Korieh A.
        • Crouzoulon G.
        Dietary regulation of fructose metabolism in the intestine and in the liver of the rat. Duration of the effects of a high fructose diet after the return to the standard diet.
        Arch Int Physiol Biochim Biophys. 1991; 99: 455-460
        • Brunt E.M.
        • Janney C.G.
        • Di Bisceglie A.M.
        • Neuschwander-Tetri B.A.
        • Bacon B.R.
        Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
        Am J Gastroenterol. 1999; 94: 2467-2474
        • Asipu A.
        • Hayward B.E.
        • O’Reilly J.
        • Bonthron D.T.
        Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria.
        Diabetes. 2003; 52: 2426-2432
        • Davies R.
        • Detheux M.
        • Van Schaftingen E.
        Fructose 1-phosphate and the regulation of glucokinase activity in isolated hepatocytes.
        Eur J Biochem. 1990; 192: 283-289
        • Weiser M.M.
        • Quill H.
        Estimation of fructokinase in crude tissue preparations.
        Anal Biochem. 1971; 43: 275-281
        • Bray G.A.
        • Nielson S.J.
        • Popkin M.B.
        Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity.
        Am J Clin Nutr. 2004; 79: 537-543
        • MacQueen H.A.
        • Sadler D.A.
        • Moore S.A.
        • Daya S.
        • Brown J.Y.
        • Shuker D.E.G.
        • et al.
        Deleterious effects of a cafeteria diet on the livers of nonobese rats.
        Nutr Res. 2007; 27: 38-47
        • Stirpe F.
        • Della Corte E.
        • Bonetti E.
        • Abbondanza A.
        • Abbati A.
        • De Stefano F.
        Fructose-induced hyperuricaemia.
        Lancet. 1970; 2: 1310-1311
        • Israel K.D.
        • Michaelis O.E.
        • Reiser S.
        • Keeney M.
        Serum uric acid, inorganic phosphorus, and glutamic-oxalacetic transaminase and blood pressure in carbohydrate-sensitive adults consuming three different levels of sucrose.
        Ann Nutr Metab. 1983; 27: 425-435
        • Reiser S.
        • Powell A.S.
        • Scholfield D.J.
        • Panda P.
        • Ellwood K.C.
        • Canary J.J.
        Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch.
        Am J Clin Nutr. 1989; 49: 832-839
        • Gao X.
        • Qi L.
        • Qiao N.
        • Choi H.K.
        • Curhan G.
        • Tucker K.L.
        • et al.
        Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women.
        Hypertension. 2007; 50: 306-312
        • Sartorio A.
        • Del Col A.
        • Agosti F.
        • Mazzilli G.
        • Bellentani S.
        • Tiribelli C.
        • et al.
        Predictors of non-alcoholic fatty liver disease in obese children.
        Eur J Clin Nutr. 2007; 61: 877-883
        • Khosla U.M.
        • Zharikov S.
        • Finch J.L.
        • Nakagawa T.
        • Roncal C.
        • Mu W.
        • et al.
        Hyperuricemia induces endothelial dysfunction.
        Kidney Int. 2005; 67: 1739-1742